304 related articles for article (PubMed ID: 24305713)
1. MDA-9/syntenin is a key regulator of glioma pathogenesis.
Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB
Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
[TBL] [Abstract][Full Text] [Related]
3. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
[TBL] [Abstract][Full Text] [Related]
4. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.
Aissaoui H; Prévost C; Boucharaba A; Sanhadji K; Bordet JC; Négrier C; Boukerche H
J Biol Chem; 2015 Feb; 290(6):3333-48. PubMed ID: 25505176
[TBL] [Abstract][Full Text] [Related]
5. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
[TBL] [Abstract][Full Text] [Related]
6. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
[TBL] [Abstract][Full Text] [Related]
7. Mda-9/syntenin promotes human brain glioma migration through focal adhesion kinase (FAK)-JNK and FAK-AKT signaling.
Zhong D; Ran JH; Tang WY; Zhang XD; Tan Y; Chen GJ; Li XS; Yan Y
Asian Pac J Cancer Prev; 2012; 13(6):2897-901. PubMed ID: 22938480
[TBL] [Abstract][Full Text] [Related]
8. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
[TBL] [Abstract][Full Text] [Related]
9. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor invasion: the roles of MDA-9/Syntenin.
Kegelman TP; Das SK; Emdad L; Hu B; Menezes ME; Bhoopathi P; Wang XY; Pellecchia M; Sarkar D; Fisher PB
Expert Opin Ther Targets; 2015 Jan; 19(1):97-112. PubMed ID: 25219541
[TBL] [Abstract][Full Text] [Related]
11. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
Hwangbo C; Kim J; Lee JJ; Lee JH
Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
[TBL] [Abstract][Full Text] [Related]
12. mda-9/Syntenin: a positive regulator of melanoma metastasis.
Boukerche H; Su ZZ; Emdad L; Baril P; Balme B; Thomas L; Randolph A; Valerie K; Sarkar D; Fisher PB
Cancer Res; 2005 Dec; 65(23):10901-11. PubMed ID: 16322237
[TBL] [Abstract][Full Text] [Related]
13. MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma.
Das SK; Bhutia SK; Azab B; Kegelman TP; Peachy L; Santhekadur PK; Dasgupta S; Dash R; Dent P; Grant S; Emdad L; Pellecchia M; Sarkar D; Fisher PB
Cancer Res; 2013 Jan; 73(2):844-54. PubMed ID: 23233738
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin.
Tian W; Wu W; Li X; Rui X; Wu Y
Biochem Biophys Res Commun; 2019 Jan; 508(1):295-301. PubMed ID: 30502089
[TBL] [Abstract][Full Text] [Related]
15. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling.
Dasgupta S; Menezes ME; Das SK; Emdad L; Janjic A; Bhatia S; Mukhopadhyay ND; Shao C; Sarkar D; Fisher PB
Clin Cancer Res; 2013 Sep; 19(17):4621-33. PubMed ID: 23873690
[TBL] [Abstract][Full Text] [Related]
16. Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma.
Notarbartolo M; Labbozzetta M; Pojero F; D'Alessandro N; Poma P
Curr Mol Med; 2018; 18(9):630-639. PubMed ID: 30608040
[TBL] [Abstract][Full Text] [Related]
17. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
[TBL] [Abstract][Full Text] [Related]
18. Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1.
Kim WY; Jang JY; Jeon YK; Chung DH; Kim YG; Kim CW
Exp Mol Med; 2014 Apr; 46(4):e90. PubMed ID: 24722482
[TBL] [Abstract][Full Text] [Related]
19. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB
Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229
[TBL] [Abstract][Full Text] [Related]
20. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1.
Lee JS; Xiao J; Patel P; Schade J; Wang J; Deneen B; Erdreich-Epstein A; Song HR
Neuro Oncol; 2014 Jan; 16(2):191-203. PubMed ID: 24305710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
